Insight

Why rates of radiation pneumonitis are high over time with raising use of immunotherapy – MSK Radiation Oncology

Photo of Narek Shaverdian taken from www.mskcc.org

Mar 29, 2024, 06:08

Why rates of radiation pneumonitis are high over time with raising use of immunotherapy – MSK Radiation Oncology

Memorial Sloan Kettering Radiation Oncology shared on X/Twitter:

“Dr. Narek Shaverdian presents at our ‘Work in Progress’ thoracic radiation oncology meeting at Memorial Sloan Kettering Cancer Center on why rates of radiation pneumonitis are high over time with raising use of immunotherapy and why it is an important target for intervention to improve lung cancer outcomes.”

Why rates of radiation pneumonitis are high over time with raising use of immunotherapy - MSK Radiation Oncology

Source: Memorial Sloan Kettering Radiation Oncology/X

cancer immunotherapy Lung cancer Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Radiation Oncology MSK Narek Shaverdian OncoDaily Oncology radiation oncology radiation pneumonitis thoracic radiation oncology Work in Progress

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage